Ginger (Zingiber officinale) supplementation for dyslipidemia and weight management: a critical review of clinical evidence
Romanian Journal of Pharmaceutical Practice · 30.06.2026 · 19 (1-2) · 30
DOI: 10.37897/rjphp.2026.1-2.4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Romanian Journal of Pharmaceutical Practice, online erschienen am 24.05.2026. Verfasst von Shah Murad und 5 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Ginger (Zingiber officinale) contains biologically active constituents with potential roles in lipid metabolism, inflammation, oxidative stress, and body-weight regulation. However, findings from clinical investigations remain inconsistent.
Objectives
To critically evaluate the available clinical evidence concerning ginger supplementation, serum lipid profiles, and weight management, considering proposed mechanisms and methodological limitations.
Methods
This narrative review examined selected randomized controlled trials, systematic reviews, meta-analyses, and an umbrella review, supported by relevant experimental investigations. Evidence was evaluated in relation to study populations, ginger preparations, dosage, treatment duration, reported outcomes, and methodological quality.
Results
Several clinical trials reported reductions in triglyceride concentrations, whereas findings concerning total cholesterol, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol were less consistent. Meta-analyses generally suggested modest improvements in selected lipid parameters, but substantial heterogeneity, overlapping primary studies, and methodological limitations reduced the certainty of these findings. Evidence concerning body weight was similarly conflicting. A recent trial involving standardized steamed ginger extract reported modest improvements in body weight and composition, whereas another controlled investigation found no significant changes in energy expenditure or anthropometric measurements. Experimental studies suggested potential mechanisms involving hepatic lipogenesis, cholesterol transport, inflammatory signaling, and intestinal microbiota, although their clinical relevance remains uncertain.
Conclusions
Ginger supplementation may provide modest improvements in selected lipid parameters, particularly triglycerides, but current evidence does not establish its efficacy as an independent treatment for dyslipidemia or obesity. Larger, longer-term clinical trials using standardized preparations are needed.
Zitieren
APA
Murad, S., Hassan, A., Saifuddin, S., Fatima, A., Firdous, A., & Shafiq, M. (2026). Ginger (Zingiber officinale) supplementation for dyslipidemia and weight management: a critical review of clinical evidence. Romanian Journal of Pharmaceutical Practice, 19(1-2), 30. https://doi.org/10.37897/rjphp.2026.1-2.4
Vancouver
Murad S, Hassan A, Saifuddin S, Fatima A, Firdous A, Shafiq M. Ginger (Zingiber officinale) supplementation for dyslipidemia and weight management: a critical review of clinical evidence. Romanian Journal of Pharmaceutical Practice. 2026;19(1-2):30. doi:10.37897/rjphp.2026.1-2.4
BibTeX
@article{Murad2026,
author = {Murad, Shah and Hassan, Azan and Saifuddin, Seema and Fatima, Ajaz and Firdous, Asia and Shafiq, Mamoona},
title = {Ginger (Zingiber officinale) supplementation for dyslipidemia and weight management: a critical review of clinical evidence},
journal = {Romanian Journal of Pharmaceutical Practice},
year = {2026},
volume = {19},
number = {1-2},
pages = {30},
doi = {10.37897/rjphp.2026.1-2.4}
}
EUVIMED